11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 1 Plenary Lecture ¥° ÁÂÀå : ±è¼º¿î
13:30~14:20 A review of current and future treatment strategies of Non-functioning pituitary adenomas John Wass, Oxford University, UK
11¿ù 20ÀÏ(Åä) - °­ÀÇ½Ç 1 Plenary Lecture ¥± ÁÂÀå : Àӽ±æ
10:20~11:10 Actions of PTH on bone H. Kronenberg, Harvard Univ., USA
11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 1 Diabetes & Obesity I - Hepatic insulin resistance ÁÂÀå : ÀÌÇü¿ì, Â÷ºÀ¼ö
10:30~12:00 Hepatic insulin resistance vs. Peripheral insulin resistance ÃÖö¼ö, °¡ÃµÀÇ´ë
°£Á¶Á÷°ú ¸»ÃÊ Àν¶¸°°¨¼ö¼º Á¶Á÷ »çÀÌ communication ÀÌ´ëÈ£, Á¦ÁÖÀÇ´ë
Hepatic insulin resistanceÀÇ Ä¡·á ±èöÈñ, ¼øõÇâÀÇ´ë
11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 1 Bone I - Beyond bisphosphonates ÁÂÀå : °­¹«ÀÏ, Á¤È£¿¬
14:20~15:50 Denosumab and other developing drugs L. Fitzpatrick (GSK, USA)
Newly developing anabolic agents ¹é±âÇö, °¡Å縯ÀÇ´ë
Newly developing (reversible) anti-resorptives °íÁ¤¹Î, ¿ï»êÀÇ´ë
11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 3 Thyroid I - Graves ophthalmopathy ÁÂÀå : ÀÌ»ó¿­ , ±Ã¼º¼ö
16:10~17:40 º´ÀÎ ¹× ±âŸ ÃÖ½ÅÁö°ß Hiromatsu Yuji, Kurume Univ., JPN
½ÇÇèÀû Ä¡·á À±Áø¼÷, ¿¬¼¼ÀÇ´ë
¾È°ú ¼ö¼úÀû Á¢±Ù ÃÖÈñ¿µ, ºÎ»êÀÇ´ë
11¿ù 20ÀÏ(Åä) - °­ÀÇ½Ç 2 Thyroid II - Thyroid cancer ÁÂÀå : Á¶º¸¿¬, ¼Û¿µ±â
08:30~10:00 Epigenetic dysregulation in thyroid cancer Tetsuo Kondo, Yamanashi Univ., JPN
(18)F-FDG Uptake and Biological Markers in Thyroid Cancer ±èÀÎÁÖ, ºÎ»êÀÇ´ë
°©»ó¼± ¾Ï¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¾ÏÀüÀÌ ¿¬±¸ ¸ðµ¨ ±¸Ãà ±èÅ¿ë, ¿ï»êÀÇ´ë
11¿ù 20ÀÏ(Åä) - °­ÀÇ½Ç 3 Bone II - Anabolic signals: Parathyroids and IGFs ÁÂÀå : ½ÅÂù¼ö, ÃÖÁ¦¿ë
08:30~10:00 Role of Ephrins in the regulation of bone formation S. Mohan , Loma Linda Univ., USA
PTH and SOST ÀÌÀ¯¹Ì, ¿¬¼¼ÀÇ´ë
Hypoparathyroidism and GCMB À̽ÃÈÆ, °¡ÃµÀÇ´ë
11¿ù 20ÀÏ(Åä) - °­ÀÇ½Ç 2 Diabetes & Obesity II - Stem cell therapy in diabetic vascular complications ÁÂÀå : À̸í½Ä, À±°ÇÈ£
11:10~12:40 Mesenchymal stem cell therapy for lower extremity ischemia ±èº´¼ö, ¼­¿ï°ø´ë
Ç÷°ü³»ÇÇ Àü±¸¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á ±Ç»ó¸ð, CHAÀÇ°úÇдëÇб³
Stem cell therapy in ischemic cardiovascular disease ÀÓµµ¼±, °í·ÁÀÇ´ë
11¿ù 20ÀÏ(Åä) - °­ÀÇ½Ç 3 Vascular biology ÁÂÀå : ±èÀÎÁÖ, À¯¼øÁý
11:10~12:40 Intravenous Endothelial-like Cells Differentiated from Mesenchymal Stem Cells Accelerate Reendothelialization in Balloon-injured Rat Ȳ±âö, ¿¬¼¼ÀÇ´ë
Homing and differentiation of endothelial progenitor cell ±Ç¿µ±Ù, ¿¬¼¼´ë
Establishment of endothelial stem cells from embryonic stem cells °í±Ô¿µ, KAIST
11¿ù 20ÀÏ(Åä) - °­ÀÇ½Ç 2 Vascular imaging - Imaging of atherosclerosis ÁÂÀå : ±èµÎ¸¸, ÀÌÀºÁ÷
15:50~17:20 MRI imaging of atherosclerosis Çã¿ë¹Î, SIRIC
Peptide Probe-Based Targeted Imaging of Atherosclerosis À̺´Çå, °æºÏÀÇ´ë
CT imaging of atherosclerosis ÃÖº´¿í, ¿¬¼¼ÀÇ´ë
11¿ù 20ÀÏ(Åä) - °­ÀÇ½Ç 3 Aging and endocrine change ÁÂÀå : ¿ìÁ¤ÅÃ, °í°æ¼ö
15:50~17:20 Aging, sarcopenia and diabetes ¹Ú¼®¿ø, CHAÀÇ°úÇдëÇб³
Aging and osteoporosis ¿À±â¿ø, ¼º±Õ°üÀÇ´ë
Aging and changes in somatotropic axis ±èµ¿¼±, ÇѾçÀÇ´ë
11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö I - ÁÁÀº¿¬±¸¸¦ À§ÇÑ ÀÇ·áÀ±¸®¿Í ¿¬±¸»ç¾÷ÀÇ ÀÌÇØ ÁÂÀå: À¯ÇüÁØ, ¹Úż±
08:40~10:10 »ç¶÷À» ´ë»óÀ¸·Î ÇÏ´Â ¿¬±¸À±¸® ±è¿ÁÁÖ, ¼­¿ïÀÇ´ë ÀÇ»çÇб³½Ç
¿¬±¸ÀÚÀÇ ±Û¾²±â À±¸® ÀÌÀÎÀç, ¼­¿ï±³´ë
³»ºÐºñ ¿¬±¸ÀÚ¸¦ À§ÇÑ ±¹Ã¥¿¬±¸ºñ ¼Ò°³ (¿¬±¸ºñ Á¾·ù¿Í °èȹ¼­ ÀÛ¼º) ÀÌÀαÔ, °æºÏÀÇ´ë
11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö ¥± - ³»ºÐºñ Á¾¾çÀÇ Áø´Ü ¹× »õ·Î¿î Ä¡·áÁ¦ ÁÂÀå: ±èµ¿¼±, ¹ÚµµÁØ
10:30~12:00 The Efficacy and safety of Pasireotide in Acromegaly and Cushing¡¯s syndrome ±è¹Î¼±, ¿ï»êÀÇ´ë
Medical treatment of pancreatic neuroendocrine tumor ÀåÈï¹®, ¿ï»êÀÇ´ë
Novel B-raf kinase inhibitor °³¹ß ½Éź¸, KIST
11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö¥² - Drug discovery and development in endocrinology and metabolism ÁÂÀå: ¹Ú°æ¼ö, ¼Û¹ÎÈ£
14:20~15:50 ´ç´¢º´ Ä¡·áÁ¦ÀÇ ÃÖ±Ù °³¹ßµ¿Çâ õÇý°æ, °¡ÃµÀÇ´ë ¾à¸®Çб³½Ç
Drug discovery in metabolic syndrome: focus on adipokines Gary Sweeny, Institut Pasteur Korea
°æ±¸¿ë Ç÷´ç°­ÇÏÁ¦ Á¦¹Ì±Û¸³Æ¾ÀÇ ¿¬±¸°³¹ß »ç·Ê ÀÓÇöÁÖ, LG»ý¸í°úÇÐ
11¿ù 19ÀÏ(±Ý) - °­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö¥³ - U-healthcare in Endocrinology ÁÂÀå: ÀåÇÐö, ·ùÁØ¿À
16:10~17:40 »óÈ£ ¿¬µ¿Àû À¯ÇコÄɾ ÀÌ¿ëÇÑ ´ç´¢º´ °ü¸® ¹× ½º¸¶Æ®ÄÉ¾î »ç¾÷ ¹ÚÁß¿­, ¿ï»êÀÇ´ë
Application of ubiquitous healthcare service using new medical information system in elderly diabetic patients ÀÓ¼ö, ¼­¿ïÀÇ´ë
À¯Çコ ¼­ºñ½º ÇöȲ ¹× À̽´ ¾È½ÃÈÆ, ºñÆ®ÄÄÇ»ÅÍ
Biosensors for U-Healthcare Á¤ºÀÇö, KRIBB